MedTrace Logo

Metabolic Reprogramming and Microenvironment in Pancreatic Adenocarcinoma

NCT07664891 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2026-06-24

No results posted yet for this study

Summary

The present project aims to elucidate the metabolic interactions within the tumor microenvironment of pancreatic adenocarcinoma, both in the primary tumor and in hepatic and pulmonary metastatic sites, as well as in circulating blood biomarkers.

Deciphering these complex interactions aims to identify exploitable vulnerabilities for predicting treatment efficacy or for guiding therapeutic strategies.

Conditions

  • Pancreatic Adenocarcinoma Metastatic

Interventions

OTHER

Biopsy collection

Tumor cells isolation

OTHER

Blood collection

Isolation of blood monocytes

Sponsors & Collaborators

  • Institut Paoli-Calmettes

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-11
Primary Completion
2028-09-01
Completion
2028-09-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07664891 on ClinicalTrials.gov